Dr. Laurie H. Glimcher, President and CEO, Dana-Farber Cancer Institute, Director of the Dana-Farber/Harvard Cancer Center and the Richard and Susan Smith Professor of Medicine at Harvard Medical School 

• Dr. Glimcher is a distinguished immunologist, widely renowned for her work in one of the most promising areas of cancer research. 
• Dr. Glimcher speaks nationally and internationally on cancer, immunology, and translational medicine and has contributed more than 350 scholarly articles and papers to medical literature. 
• Aside from her research efforts, Dr. Glimcher is a staunch proponent of improved access to care, health policy, and medical education, while simultaneously serving as a pioneering mentor and role model for cancer research trainees and for all women in science. 
• She was the first female to be appointed as dean of Weill Cornell Medicine in New York and is the first female President and Chief Executive Officer of Dana-Farber Cancer Institute in Boston.